Maximizing Efficiency in Robotic Cholecystectomy
A new service evaluation reveals that implementing high-intensity theatre (HIT) principles can double productivity for robotic cholecystectomy.
Newsletter
General Surgery
Best Papers in General Surgery
The five that matter, every day.
Trisectionectomies Enhance Outcomes in Bismuth Type II-III Cholangiocarcinoma
Trisectionectomies significantly improve survival for patients with localized Bismuth-Corlette type II-III perihilar cholangiocarcinoma.
Liver Resection for Colorectal Metastases Sets New Outcomes Benchmark
Liver resection remains a gold standard for colorectal liver metastases, providing critical data for patient selection and surgical outcomes.
New model predicts early recurrence risk in pancreatic tumors
Surgeons can now identify non-functioning pancreatic neuroendocrine tumors at high risk for early recurrence preoperatively.
New AI Model Detects Perineural Invasion in Colorectal Cancer
This machine learning model improves detection of perineural invasion (PNI) in colorectal cancer, crucial for surgical outcomes.
New model predicts poor outcomes in liver surgery for HCC
Surgeons now have a validated model to identify patients at high risk for early non-curative recurrence after liver resection for hepatocellular carcinoma (HCC), crucial for tailoring postoperative care.
ICG Navigation Outperforms Conventional Technique for Hepatic Hemangioma
Using indocyanine green (ICG) fluorescence navigation in laparoscopic hepatectomy leads to better outcomes for hepatic hemangioma patients.
Liposomal Bupivacaine Beats Ropivacaine for Hemorrhoid Surgery
Liposomal bupivacaine provides superior pain relief compared to ropivacaine for patients post-hemorrhoidectomy.
Extended thromboprophylaxis cuts VTE rates in colorectal surgery
Extended thromboprophylaxis significantly reduces venous thromboembolism (VTE) risk after colorectal surgery without increasing bleeding complications.
Surgical Resection Boosts Survival in HCC After Triple Therapy
Surgical resection significantly improves survival for hepatocellular carcinoma patients who reach complete response following triple therapy.